Jula Inrig
CHIEF MEDICAL OFFICER · 2 filings · Latest: May 4, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | May 6, 2026 | Sale | $43.95 | 311 | $13.7K | 113,238 | |
TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | May 5, 2026 | Sale | $46.65 | 2,174 | $101.4K | 113,549 | |
TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | May 4, 2026 | Sale | $45.00 | 20,000 | $900.0K | 111,473 | |
TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | May 4, 2026 | Option Exercise | $18.47 | 24,250 | $448.0K | 115,723 | |
TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | Apr 15, 2026 | Sale | $42.61 | 1,018 | $43.4K | 111,473 | |
TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | Apr 14, 2026 | Sale | $41.93 | 7,215 | $302.5K | 112,491 | |
TVTX | Jula Inrig | CHIEF MEDICAL OFFICER | Apr 13, 2026 | Grant/Award | $0.00 | 14,000 | — | 119,706 |